Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Description

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Conditions

Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm

Study Overview

Study Details

Study overview

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Condition
Central Nervous System Neoplasm
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
  • * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
  • * An in-person visit
  • * A telemedicine appointment
  • * Encounter occurred with the assistance of official language translation support
  • * Patients with telephone encounters (without interactive video)
  • * New patient or consult visits
  • * Neither patient nor caregiver present during the visit are available or able to answer survey questions

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Barbara J O'Brien, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2026-12-31